|
85
|
259
|
3lunA |
Structure of ulilysin mutant m290c |
|
60
|
191
|
3lmcA |
Crystal structure of zinc-dependent peptidase from methanocorpusculum labreanum (strain z), northeast structural genomics consortium target mur16 |
|
84
|
258
|
3leaA |
Crystal structure of the catalytic domain of tace with isoindolinone-biphenyl-hydantoin inhibitor |
|
75
|
218
|
3ljtA |
Crystal structure of the catalytic domain of adamts-5 in complex with an amino-2-indanol compound |
|
87
|
262
|
3lumA |
Structure of ulilysin mutant m290l |
|
51
|
222
|
3kwvC |
Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers |
|
83
|
259
|
3l0vA |
Crystal structure of catalytic domain of tace with the first hydantoin inhibitor occupying the s1' pocket |
|
81
|
257
|
3l0tA |
Crystal structure of catalytic domain of tace with hydantoin inhibitor |
|
80
|
257
|
3kmeA |
Crystal structure of catalytic domain of tace with phenyl-pyrrolidinyl-tartrate inhibitor |
|
43
|
167
|
3kecA |
Crystal structure of human mmp-13 complexed with a phenyl-2h-tetrazole compound |
|
44
|
163
|
3kejA |
Crystal structure of human mmp-13 complexed with a (pyridin-4-yl)-2h-tetrazole compound |
|
44
|
164
|
3kekA |
Crystal structure of human mmp-13 complexed with a (pyridin-4-yl)-2h-tetrazole compound |
|
74
|
238
|
3khiA |
Crystal structure of a putative metal-dependent hydrolase (yp_001336084.1) from klebsiella pneumoniae subsp. pneumoniae mgh 78578 at 1.95 a resolution |
|
81
|
257
|
3kmcA |
Crystal structure of catalytic domain of tace with tartrate-based inhibitor |
|
46
|
164
|
3kryA |
Crystal structure of mmp-13 in complex with sc-78080 |
|
110
|
422
|
3k7lA |
Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the d domain of adamalysin family proteins |
|
112
|
396
|
3k7nA |
Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the d domain of adamalysin family proteins |
|
74
|
217
|
3hy9A |
Crystal structure of the catalytic domain of adamts-5 in complex with an amino-2-indanol compound |
|
73
|
217
|
3hy7A |
Crystal structure of the catalytic domain of adamts-5 in complex with marimastat |
|
46
|
169
|
3i7gA |
Mmp-13 in complex with a non zinc-chelating inhibitor |
|
73
|
217
|
3hygA |
Crystal structure of the catalytic domain of adamts-5 in complex with an amino-2-indanol compound |
|
44
|
169
|
3i7iA |
Mmp-13 in complex with a non zinc-chelating inhibitor |
|
124
|
419
|
3hdaP |
Prtc methionine mutants: m226a_desy |
|
123
|
419
|
3hbvP |
Prtc methionine mutants: m226a in-house |
|
158
|
462
|
3hbuP |
Prtc methionine mutants: m226h desy |
|
161
|
462
|
3hb2P |
Prtc methionine mutants: m226i |
|
123
|
417
|
3hdbA |
Crystal structure of aahiv, a metalloproteinase from venom of agkistrodon acutus |
|
84
|
254
|
3g42A |
Crystal structure of tace with tryptophan sulfonamide derivative inhibitor |
|
73
|
200
|
3gboA |
Crystal structure of bmoompalpha-i, a non-hemorrhagic metalloproteinase isolated from bothrops moojeni snake venom |
|
128
|
486
|
3g5cA |
Structural and biochemical studies on the ectodomain of human adam22 |
|
43
|
158
|
3f16A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (r)-n-(3-hydroxy-1-nitroso-1-oxopropan-2-yl)-4-methoxybenzenesulfonamide |
|
44
|
158
|
3f19A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor 4-fluoro-n-(2-nitroso-2-oxoethyl)benzenesulfonamide |
|
83
|
258
|
3ewjA |
Crystal structure of catalytic domain of tace with carboxylate inhibitor |
|
42
|
158
|
3f17A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-(2-nitroso-2-oxoethyl)biphenyl-4-sulfonamide |
|
44
|
158
|
3f15A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (s)-n-(2,3-dihydroxypropyl)-4-methoxy-n-(2-nitroso-2-oxoethyl)benzenesulfonamide |
|
45
|
158
|
3f1aA |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-(2-nitroso-2-oxoethyl)benzenesulfonamide |
|
43
|
158
|
3f18A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor 4-fluoro-n-(2-hydroxyethyl)-n-(2-nitroso-2-oxoethyl)benzenesulfonamide |
|
65
|
201
|
3ediA |
Crystal structure of tolloid-like protease 1 (tll-1) protease domain |
|
80
|
258
|
3edzA |
Crystal structure of catalytic domain of tace with hydroxamate inhibitor |
|
44
|
158
|
3ehyA |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (r)-2-(4-methoxyphenylsulfonamido)propanoic acid |
|
68
|
201
|
3edgA |
Crystal structure of bone morphogenetic protein 1 protease domain |
|
45
|
158
|
3ehxA |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (r)-2-(biphenyl-4-ylsulfonamido)-4-methylpentanoic acid |
|
48
|
169
|
3elmA |
Crystal structure of mmp-13 complexed with inhibitor 24f |
|
66
|
201
|
3edhA |
Crystal structure of bone morphogenetic protein 1 protease domain in complex with partially bound dmso |
|
119
|
416
|
3dslA |
The three-dimensional structure of bothropasin, the main hemorrhagic factor from bothrops jararaca venom. |
|
70
|
256
|
3dteA |
Crystal structure of the irre protein, a central regulator of dna damage repair in deinococcaceae |
|
71
|
256
|
3dtkA |
Crystal structure of the irre protein, a central regulator of dna damage repair in deinococcaceae |
|
73
|
256
|
3dtiA |
Crystal structure of the irre protein, a central regulator of dna damage repair in deinococcaceae |
|
80
|
257
|
3e8rA |
Crystal structure of catalytic domain of tace with hydroxamate inhibitor |
|
243
|
670
|
3dwbA |
Structure of human ece-1 complexed with phosphoramidon |
